PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus

NCT04496401 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nantes University Hospital

Collaborators